Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zibo Qianhui Biological Technology is a specialized manufacturer of cyclodextrins and their derivatives based in Shandong, China. The company focuses on producing high-quality pharmaceutical excipients, including Hydroxypropyl Betadex and Sulfobutyl Ether Beta Cyclodextrin Sodium, which are essential for enhancing the solubility and stability of active pharmaceutical ingredients. Zibo Qianhui's facilities are GMP-compliant, and the company holds several Drug Master File (DMF) registrations with international regulatory bodies like the US FDA and China's NMPA. Their products serve a diverse range of industries, including pharmaceuticals, nutraceuticals, and cosmetics, supporting drug delivery innovations worldwide. The company is recognized as a leading professional producer of cyclodextrin series in the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zibo Qianhui Biological Technology.